The Alfred: Clinical Trials

7 trials sponsored by The Alfred, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow The Alfred: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
Healthy lung sparing treatment plan - Lung Cancer
Phase 3RecruitingUniversity of Sydney1652026-01-012026-05-19
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Atorvastatin, Standard Care - Neurocognitive Impairment, Mild
Phase 3Active not recruitingThe George Institute1902022-03-102025-04-10
Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Home-based pulmonary rehabilitation, Hospital-based pulmonary rehabilitation - Chronic Obstructive Pulmonary Disease
Phase 3CompletedLa Trobe University1442011-10-012019-08-14
The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis
Hypertonic saline 6% - - Bronchiectasis
Phase 3CompletedThe Alfred402007-12-012011-06-23
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
N-acetylcysteine - Heart Failure, Congestive, Kidney Failure, Chronic
Phase 2 / Phase 3UnknownBayside Health102007-09-012007-09-20
Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease
Nesiritide, Placebo - Heart Failure
Phase 3TerminatedThe Alfred62007-09-012015-06-25
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Coversyl (perindopril) - Marfan Syndrome
Phase 3CompletedBayside Health172004-01-012007-06-13

Conditions studied

Heart Failure (2)  ·  Bronchiectasis (1)  ·  COVID-19 (1)  ·  Dyspnea (1)  ·  Kidney Failure, Chronic (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Follicular (1)  ·  Marfan Syndrome (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Neurologic Manifestations (1)  ·  Pneumonia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Renal Insufficiency (1)

Interventions

Acetylcysteine (1)  ·  Atorvastatin (1)  ·  Natriuretic Peptide, Brain (1)  ·  Perindopril (1)  ·  Standard of Care (1)

Countries

Australia (6)

Top investigators

Ajay Mahal, PhD (1)  ·  Anne E Holland, PhD (1)  ·  Anne Holland, PhD, BAppSc (1)  ·  Anthony Camuglia, MBBS (1)  ·  Bronwyn A Kingwell, PhD (1)  ·  Caroline H Nicolson, MPhysio (1)  ·  Catherine Farrrington (1)  ·  Christine F McDonald, PhD (1)  ·  Craig Anderson, MD (1)  ·  David Kaye, PhD FRACP (1)  ·  Henry Krum, MBBS FRACP PhD (1)  ·  Jenny Starr (1)  ·  Paul Keall, PhD (1)  ·  Peter Cameron (1)

Results publications

PMID 17911499, PMID 22349069, PMID 23219310, PMID 24011178, PMID 27672116, PMID 30316548, PMID 30688793, PMID 31239657, PMID 31418515, PMID 33228654, PMID 33511633, PMID 40228860